PDCD1 and neoplasm: In a late-stage metastatic B16–F10-Luc2 melanoma model, we showed that α-PD-1 had no control over tumour growth or mitigating the widespread metastasis, demonstrating how this advanced melanoma model had poor response to PD-1 blockade therapy (Fig. 6a, b).